LEADER 02785oam 2200445 450 001 9910813380203321 005 20190911103514.0 010 $a1-4698-5046-X 010 $a1-78402-610-7 010 $a1-4698-7405-9 035 $a(OCoLC)880218580 035 $a(MiFhGG)GVRL8SZF 035 $a(EXLCZ)993710000000088820 100 $a20130430h20142014 uy 0 101 0 $aeng 135 $aurun|---uuuua 181 $ctxt 182 $cc 183 $acr 200 02$aA clinical guide to gluten-related disorders /$f[edited by] Alessio Fasano, medical director, Mucosal Immunology and Biology Research Center and Center for Celiac Research, Massachusetts General Hospital, Division of Pediatric Gastroenterology and Nutrition, Massachusetts General Hospital for Children, Boston, Massachusetts 205 $aFirst edition. 210 1$aPhiladelphia :$cWolters Kluwer Health / Lippincott Williams & Wilkins,$d[2014] 210 4$d?2014 215 $a1 online resource (xviii, 172 pages) $cillustrations 225 0 $aGale eBooks 300 $a"Nasphghan Foundation for Children's Digestive Health & Nutrition." 311 $a1-4511-8263-5 320 $aIncludes bibliographical references and index. 327 $aIntroduction to gluten spectrum disorders / Alessio Fasano -- Celiac disease / Stefano Guandalini, Valentina Discepolo, Catherine Newland, Sonia Kupfer -- Gluten sensitivity / Carlo Catassi, Elena Lionetti, Anna Sapone -- Wheat allergy / Joseph Levy, Nomi Levy-Carrick -- Diagnosis / Ivor Hill, Tina Rakitt -- Treatment / Pam Cureton, Suzanne Simpsony?, Anne Lee, Tricia Thompson, Cynthia Kupper, Mary K. Sharrett -- Psychosocial aspects of gluten spectrum disorders / Naina Mehta, Yamen Smadi, Devendra I. Mehta, Karoly Horvath -- Difficult cases / Edward J. Hoffenberg, Thomas Flass, Joel Friedlander, Edwin Liu, Robert Kramer. 330 $aA Clinical Guide to Gluten-Related Disorders provides primary health care providers the succinct material they need to immediately evaluate and support their patients. Gluten-related disorders have a wide presentation, and this text covers the recognition, evaluation, and multi-disciplinary approach to the management of disease. Readers will benefit from the general overview of gluten intolerance and from the common sense approach to developing treatment and dietary plans. Clinical vignettes offer clinicians real-life scenarios to help put the disease and its treatment in context for their pat 606 $aCeliac disease 615 0$aCeliac disease. 676 $a616.3/99 702 $aFasano$b Alessio 801 0$bMiFhGG 801 1$bMiFhGG 906 $aBOOK 912 $a9910813380203321 996 $aA clinical guide to gluten-related disorders$94000518 997 $aUNINA LEADER 01683nas 22005653 450 001 996202309403316 005 20230518213020.0 011 $a1944-7655 035 $a(OCoLC)42612046 035 $a(CKB)954921406258 035 $a(CONSER)--2008212223 035 $a(EXLCZ)99954921406258 100 $a19991011a19869999 k-- a 101 0 $aeng 135 $aurunu|||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 00$aNetwork world 210 1$aFramingham, MA :$c[CW Communications] 215 $a1 online resource 311 $a0887-7661 517 1 $aNW 517 1 $aNWW 531 $aNetwork World 606 $aComputers$vPeriodicals 606 $aComputer networks$vPeriodicals 606 $aTelecommunication$vPeriodicals 606 $aElectronic data processing$vPeriodicals 606 $aComputers$xperiodicals 606 $aComputer networks$2fast$3(OCoLC)fst00872297 606 $aComputers$2fast$3(OCoLC)fst00872776 606 $aElectronic data processing$2fast$3(OCoLC)fst00906956 606 $aTelecommunication$2fast$3(OCoLC)fst01145830 608 $aWeb sites. 608 $aPeriodicals.$2fast 610 $aComputing, mathematics and information systems 615 0$aComputers 615 0$aComputer networks 615 0$aTelecommunication 615 0$aElectronic data processing 615 2$aComputers$xperiodicals. 615 7$aComputer networks. 615 7$aComputers. 615 7$aElectronic data processing. 615 7$aTelecommunication. 906 $aJOURNAL 912 $a996202309403316 996 $aNetwork world$92220765 997 $aUNISA LEADER 05970nam 22006615 450 001 9910886076503321 005 20260320130501.0 010 $a981-9751-65-9 024 7 $a10.1007/978-981-97-5165-5 035 $a(MiAaPQ)EBC31626740 035 $a(Au-PeEL)EBL31626740 035 $a(CKB)34512778500041 035 $a(DE-He213)978-981-97-5165-5 035 $a(EXLCZ)9934512778500041 100 $a20240829d2024 u| 0 101 0 $aeng 135 $aurcnu|||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aAdvances in Antifungal Drug Development $eNatural Products with Antifungal Potential /$fedited by Nikhat Manzoor 205 $a1st ed. 2024. 210 1$aSingapore :$cSpringer Nature Singapore :$cImprint: Springer,$d2024. 215 $a1 online resource (723 pages) 311 08$a981-9751-64-0 320 $aIncludes bibliographical references. 327 $aPart I: Introduction -- An Update on Human Fungal Diseases: A Holistic Overview -- Part II: Plant Extracts and Essential Oils as antifungals -- Composition of different species of Lamiaceae plant family: A potential bio-source of terpenoids and antifungal agents -- Plant Essential Oils and their Active Ingredients -- Essential Oils and Their Compounds for Applications in Fungal Diseases: Conventional and Non-conventional Approaches -- Antifungal efficacy of plant essential oils against Candida, Aspergillus and Cryptococcus species -- Unveiling the Potential of Essential Oils as Antifungal Agents Against Non-albicans Candida Species: Mechanisms of Action and Therapeutic Implications -- Part III: Plant derived natural compounds as antifungals -- Molecules of natural origin as inhibitors of signal transduction pathway in Candida albicans -- Harnessing the antifungal potential of natural products -- Clinical Significance, Molecular Formation, and Natural Antibiofilm Agents of Candida albicans -- Futuristic Avenues in Candida Treatment: Exploiting Plant Derived agents as potent inhibitors of Candidiasis -- Antifungal efficacy of Terpenes and mechanism of action against human pathogenic fungi -- Part IV: Plant based nanoparticles as antifungals -- Exploration of new plant-based nanoparticles with potential antifungal activity and their mode of action -- Green-synthesized nanoparticles: Characterization and Antifungal mechanism of action -- Green-synthesized nanoparticles: Antifungal efficacy and other applications -- Metal nanoparticles: management and control of phytopathogenic fungi -- Phytosynthesized Nanoparticles: Antifungal activity and mode of action -- Antifungal Efficacy of Plant-based Nanoparticles as a putative tool for antifungal therapy -- Part V: Plant based chemical derivatives as antifungals -- Antifungal Efficacy of Natural Product-Based Chemical Derivatives -- Therapeutic potential of phytochemicals and their derivatives as antifungal candidates: Recent discovery and development -- Bioactive Heterocyclic Analogs as Antifungal Agents: Recent Advances and Future Aspects -- Part VI: Natural products derived from microbes and other natural sources -- Bioactive potential of Streptomyces spp. against diverse pathogenic fungi -- Antifungal potential of bioactive compounds derived from microbes and other natural sources: Challenges and future scope -- Microbial and plant natural products and their antifungal targets -- Part VII: Toxicology of natural antifungals and other applications -- Toxicology of antifungal and antiviral drugs -- Natural Compounds Toxicity: An Egregiously Overlooked Topic -- Fungal infestation of biodegradable heritage material: application of conservatory treatments and characterization of the article -- Antifungals Discovery and Bioinformatics Tools. 330 $aThis book explores the antifungal properties of natural products and reviews their antifungal mechanism. An introductory chapter illustrates the various fungal pathogenic species, common fungal diseases, and general mechanisms of action of various antifungal classes, including natural products. The book comprises seven sections and each section contains chapters on the efficacy and antifungal mode of action of plant extracts, essential oils, natural compounds, their derivatives, and plant-based nanoparticles. A section summarizes the antifungal efficacy of compounds derived from sources other than plants, like microbes. Besides compound toxicity, the book explores the antifungal mode of action and efficacy against the virulence and pathogenicity of fungal pathogens like Candida, Aspergillus, Cryptococcus, Histoplasma, and other pathogenic fungi. Further, the book also describes recent advancements in the discovery of novel drug targets and therapeutic strategies that are non-toxic and more efficacious for combating drug resistance. This book is an invaluable source for researchers working in the field of fungal biochemistry, anti-microbial, and anti-bacterial and undergraduate and postgraduate students of microbiology and pharmacology. 606 $aPharmacology 606 $aMedical microbiology 606 $aFungi 606 $aMycology 606 $aMicrobiology 606 $aPharmacology 606 $aFungi 606 $aMedical Microbiology 606 $aMedicaments antifúngics$2thub 606 $aProductes naturals$2thub 608 $aLlibres electrònics$2thub 615 0$aPharmacology. 615 0$aMedical microbiology. 615 0$aFungi. 615 0$aMycology. 615 0$aMicrobiology. 615 14$aPharmacology. 615 24$aFungi. 615 24$aMedical Microbiology. 615 7$aMedicaments antifúngics 615 7$aProductes naturals 676 $a615.792 702 $aManzoor$b Nikhat 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910886076503321 996 $aAdvances in Antifungal Drug Development$94431443 997 $aUNINA